- Presence of candidemia or invasive candidiasis.
- Presence of one or more of signs and symptoms of acute fungal infection.
- Subjects who received greater than 48 hours of systemic antifungal treatment for the
Candida infection for which they will be enrolled.
- Subjects with hypersensitivity to echinocandins or azole therapy or drug excipients.